These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 30443279)

  • 21. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
    Boriani G; Merino J; Wright DJ; Gadler F; Schaer B; Landolina M
    Europace; 2018 Dec; 20(12):1882-1897. PubMed ID: 29757390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health Care Utilization and Expenditures Associated With Remote Monitoring in Patients With Implantable Cardiac Devices.
    Ladapo JA; Turakhia MP; Ryan MP; Mollenkopf SA; Reynolds MR
    Am J Cardiol; 2016 May; 117(9):1455-62. PubMed ID: 26996767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remote Monitoring of Permanent Pacemakers and Implantable Cardioverter Defibrillators.
    Wilner B; Rickard J
    Card Electrophysiol Clin; 2021 Sep; 13(3):449-457. PubMed ID: 34330372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Low Critical Event Rate Despite a High Abnormal Event Rate in Patients with Cardiac Implantable Electric Devices Followed Up by Remote Monitoring.
    Morimoto Y; Nishii N; Tsukuda S; Kawada S; Miyamoto M; Miyoshi A; Nakagawa K; Watanabe A; Nakamura K; Morita H; Ito H
    Intern Med; 2019 Aug; 58(16):2333-2340. PubMed ID: 31118368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database.
    Lazarus A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S2-S12. PubMed ID: 17302706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of remote monitoring on clinical events and associated health care utilization: A nationwide assessment.
    Piccini JP; Mittal S; Snell J; Prillinger JB; Dalal N; Varma N
    Heart Rhythm; 2016 Dec; 13(12):2279-2286. PubMed ID: 27544748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study.
    Guédon-Moreau L; Lacroix D; Sadoul N; Clémenty J; Kouakam C; Hermida JS; Aliot E; Kacet S;
    Europace; 2014 Aug; 16(8):1181-8. PubMed ID: 24614572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience.
    Liberska A; Kowalski O; Mazurek M; Lenarczyk R; Jędrzejczyk-Patej E; Przybylska-Siedlecka K; Kozieł M; Morawski S; Podolecki T; Kowalczyk J; Pruszkowska P; Pluta S; Sokal A; Kalarus Z
    Kardiol Pol; 2016; 74(8):741-748. PubMed ID: 26898970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic impact of remote monitoring after implantable defibrillators implantation in heart failure patients: an analysis from the EFFECT study.
    Capucci A; De Simone A; Luzi M; Calvi V; Stabile G; D'Onofrio A; Maffei S; Leoni L; Morani G; Sangiuolo R; Amellone C; Checchinato C; Ammendola E; Buja G
    Europace; 2017 Sep; 19(9):1493-1499. PubMed ID: 28407139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
    Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost efficiency and reimbursement of remote monitoring: a US perspective.
    Slotwiner D; Wilkoff B
    Europace; 2013 Jun; 15 Suppl 1():i54-i58. PubMed ID: 23737232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large Controlled Observational Study on Remote Monitoring of Pacemakers and Implantable Cardiac Defibrillators: A Clinical, Economic, and Organizational Evaluation.
    Dario C; Delise P; Gubian L; Saccavini C; Brandolino G; Mancin S
    Interact J Med Res; 2016 Jan; 5(1):e4. PubMed ID: 26764170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.
    Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F
    Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2017 Mar; 5(3):204-212. PubMed ID: 28254126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK.
    Burri H; Sticherling C; Wright D; Makino K; Smala A; Tilden D
    Europace; 2013 Nov; 15(11):1601-8. PubMed ID: 23599169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure.
    Woo CY; Strandberg EJ; Schmiegelow MD; Pitt AL; Hlatky MA; Owens DK; Goldhaber-Fiebert JD
    Ann Intern Med; 2015 Sep; 163(6):417-26. PubMed ID: 26301323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction.
    McAlister FA; Ezekowitz J; Dryden DM; Hooton N; Vandermeer B; Friesen C; Spooner C; Rowe BH
    Evid Rep Technol Assess (Full Rep); 2007 Jun; (152):1-199. PubMed ID: 17764218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients.
    Varma N; Piccini JP; Snell J; Fischer A; Dalal N; Mittal S
    J Am Coll Cardiol; 2015 Jun; 65(24):2601-2610. PubMed ID: 25983008
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.